These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 20851179
1. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin. Prast-Nielsen S, Cebula M, Pader I, Arnér ES. Free Radic Biol Med; 2010 Dec 01; 49(11):1765-78. PubMed ID: 20851179 [Abstract] [Full Text] [Related]
2. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y, Folan M, Shaw M, Messer RL, Lockwood PE, Hobbs D, Bouillaguet S, Sano H, Lewis JB, Wataha JC. Toxicol In Vitro; 2006 Sep 01; 20(6):882-90. PubMed ID: 16510263 [Abstract] [Full Text] [Related]
3. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, Björnstedt M, Bindoli A, Sturaro A, Rella R, Marzano C. Biochem Pharmacol; 2010 Jan 15; 79(2):90-101. PubMed ID: 19665452 [Abstract] [Full Text] [Related]
4. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Rackham O, Shearwood AM, Thyer R, McNamara E, Davies SM, Callus BA, Miranda-Vizuete A, Berners-Price SJ, Cheng Q, Arnér ES, Filipovska A. Free Radic Biol Med; 2011 Mar 15; 50(6):689-99. PubMed ID: 21172426 [Abstract] [Full Text] [Related]
5. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302. Li S, Zhang J, Li J, Chen D, Matteucci M, Curd J, Duan JX. Biol Trace Elem Res; 2010 Sep 15; 136(3):294-301. PubMed ID: 19838642 [Abstract] [Full Text] [Related]
6. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents. Schuh E, Pflüger C, Citta A, Folda A, Rigobello MP, Bindoli A, Casini A, Mohr F. J Med Chem; 2012 Jun 14; 55(11):5518-28. PubMed ID: 22621714 [Abstract] [Full Text] [Related]
7. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Witte AB, Anestål K, Jerremalm E, Ehrsson H, Arnér ES. Free Radic Biol Med; 2005 Sep 01; 39(5):696-703. PubMed ID: 16085187 [Abstract] [Full Text] [Related]
10. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate. Zhang H, Cao D, Cui W, Ji M, Qian X, Zhong L. Free Radic Biol Med; 2010 Dec 15; 49(12):2010-8. PubMed ID: 20951799 [Abstract] [Full Text] [Related]
12. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Arnér ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G. Free Radic Biol Med; 2001 Nov 15; 31(10):1170-8. PubMed ID: 11705695 [Abstract] [Full Text] [Related]
15. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Cassidy PB, Edes K, Nelson CC, Parsawar K, Fitzpatrick FA, Moos PJ. Carcinogenesis; 2006 Dec 15; 27(12):2538-49. PubMed ID: 16777982 [Abstract] [Full Text] [Related]
16. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity. Lessa JA, Guerra JC, de Miranda LF, Romeiro CF, Da Silva JG, Mendes IC, Speziali NL, Souza-Fagundes EM, Beraldo H. J Inorg Biochem; 2011 Dec 15; 105(12):1729-39. PubMed ID: 22005449 [Abstract] [Full Text] [Related]